EcoDrugPlus

Solute Carrier Family 6 Member 3

Ensembl ID : ENSLACG00000002305
Gene Symbol: SLC6A3
2 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSLACG00000014325
Gene Symbol: SLC6A4
4 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSLACG00000004060
Gene Symbol: SLC6A9
4 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSLACG00000010520
Gene Symbol: SLC9A3
4 Cross references
234 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSLACG00000010722
Gene Symbol: SSTR1
4 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSLACG00000018502
Gene Symbol: SSTR2
4 Cross references
263 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSLACG00000006335
Gene Symbol: SSTR5
4 Cross references
219 Possible Orthologues:

Somatostatin Receptor Type 1-Like

Ensembl ID : ENSLACG00000007184
Gene Symbol: LOC102349660
3 Cross references
57 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSLACG00000008598
Gene Symbol: SPHK2
4 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSLACG00000002761
Gene Symbol: S1PR1
4 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSLACG00000011436
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSLACG00000022285
Gene Symbol: SRD5A2
4 Cross references
263 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).